InvestorsObserver
×
News Home

Spark Therapeutics (ONCE) Stock Boosted 120% by Roche Merger

Monday, February 25, 2019 03:13 PM | Brad Spears

Mentioned in this article

Spark Therapeutics (ONCE) Stock Boosted 120% by Roche Merger

Shares of Spark Therapeutics (ONCE) stock are up more than 120% Monday following an announcement that the company will be acquired by Roche Holdings (RHHBY). In the merger agreement, Roche Holdings will acquire Spark Therapeutics in an all-cash transaction for $114.50 per share.

The $114.50 per share price reflect a total equity value of approximately $4.8 billion, which is a premium of +122% of the stocks’ closing price Friday, Feb 22.

The merger agreement was unanimously approved by both companies’ board members, with a closing date expected in the second quarter of 2019.

Spark Therapeutics stock is currently trading at $113.53 as of 3:06 PM on Monday, Feb 25, a gain of $61.97, or 120.19% from the previous closing price of $51.56. ONCE stock has traded between $113.41 and $114.20 so far today. Volume today is high. So far 14,309,991 shares have traded compared to average volume of 452,576 shares.

Meanwhile, the major indices are rallying. The NASDAQ is higher by 0.61%. The Dow Jones Industrial Average is higher by 0.47%. The S&P 500 is higher by 0.34%.

Stock Score Report, InvestorsObserver’s proprietary scoring system, gives ONCE stock a score of 67 out of a possible 100. That score is based on three component scores. A fundamental score of 1, a long-term technical score of 100 and a short-term technical score of 100.

Our proprietary system combines short and long-term technical factors, Wall Street’s opinion, and other fundamental factors into an overall score that measures a stock’s suitability for investment.

Get more analysis and trade ideas on Spark Therapeutics (ONCE) stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App